In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • How Does Preoperative Smoking History Impact Anterior Cervical Discectomy and Fusion Outcomes?

    Final Number:
    1608

    Authors:
    Taylor Elise Purvis BA; Haroldo J. Rodriguez; Ali Karim Ahmed BS MD candidate; Christine Elizabeth Boone; Rafael De la Garza Ramos MD; C. Rory Goodwin MD PhD; Daniel M. Sciubba MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: Studies that examine the relationship between preoperative smoking and morbidity following anterior cervical discectomy and fusion (ACDF) surgery are conflicting. No studies previously have used a national database to assess the impact of preoperative smoking on perioperative complications among ACDF patients. We sought to compare perioperative complication rates among current smokers, non-smokers, and ever-smokers undergoing ACDF surgery.

    Methods: The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was queried for adults who underwent non-emergent ACDF surgery between 2005 and 2014. Preoperative smoking status—current smoker, non-smoker, or ever-smoker—was obtained. Variables analyzed included in-hospital mortality, development of a major complication, development of at least one complication, and length of hospital stay.

    Results: A total of 25,869 patients undergoing ACDF were identified; 7,847 (30.3%) current smokers, 18,022 (69.7%) not currently smoking, and 8542 (33.0%) ever-smokers. Current smokers did not have increased odds of developing any one complication (OR, 1.054; 95% CI, 0.874-1.271; P=0.584) or any major complication (OR, 1.233; 95% CI, 0.935-1.627; P=0.138). Ever-smokers did have higher odds of any major complication (OR, 1.333; 95% CI 1.007-1.764; P=0.044) than patients who had never smoked. The number of pack-years was not significantly associated with greater odds of developing any one complication (OR, 0.992; 95% CI, 0.978-1.006; P=0.276) or any major complication (OR, 0.991; 95% CI, 0.972-1.010; P=0.334).

    Conclusions: ACDF patients who smoke pre-operatively do not demonstrate higher rates of 30-day morbidity than patients not currently smoking. Patients who have ever smoked should be considered higher risk than never-smokers when undergoing ACDF.

    Patient Care: Clinicians will be able to identify patients with a positive smoking history who may be at increased risk for complications following ACDF.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe the impact of preoperative smoking status on ACDF surgical outcomes; 2) Consider, in small groups, ways to discuss potential surgical risk with patients who have a positive ever-smoker status.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy